Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in pa... by Pouleur, A-C, Anker, S, Brito, D, Brosteanu, O, Hasenclever, D, Casadei, BS, Edelmann, F, Filippatos, G, Gruson, D, Ikonomidis, I, Lhommel, R, Mahmod, M, Neubauer, SK, Persu, A, Gerber, BL, Piechnik, S, Pieske, B, Pieske-Kraigher, E, Pinto, F, Ponikowski, P, Senni, M, Trochu, J-N, Van Overstraeten, N, Wachter, R, Balligand, J-L